SCHEMBL19980167

SCHEMBL19980167

CCOC(=O)/C(=N/NCc1ccccc1)NC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
SMN1; SMN2 Q16637 5/20 0.47
PPID Q08752 1/20 0.46
MAPT P10636 4/20 0.43
LMNA P02545 3/20 0.42
GAA P10253 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
NPSR1 Q6W5P4 2/20 0.41
HPGD P15428 1/20 0.41
NAMPT P43490 1/20 0.41
ATM Q13315 1/20 0.41
KDM4E B2RXH2 1/20 0.40
HSP90AA1 P07900 1/20 0.40
HSP90AB1 P08238 1/20 0.40
APEX1 P27695 1/20 0.40
RECQL P46063 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
RIPK1 Q13546 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13212654 0.85 SMN1; SMN2 (0.49) ALDH1A1SMN1; SMN2PPIDMAPTLMNA
SCHEMBL15334000 0.85 SMN1; SMN2 (0.49) ALDH1A1SMN1; SMN2PPIDMAPTLMNA
SCHEMBL12481397 0.85 SMN1; SMN2 (0.49) ALDH1A1SMN1; SMN2PPIDMAPTLMNA
SCHEMBL25882415 0.84 MAPT (0.51) ALDH1A1SMN1; SMN2PPIDMAPTLMNA
SCHEMBL19980197 0.81 MEN1 (0.48) ALDH1A1SMN1; SMN2PPIDMAPTLMNA
SCHEMBL13406756 0.81 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2PPIDMAPTLMNA
SCHEMBL25882277 0.81 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2PPIDMAPTLMNA
SCHEMBL14606969 0.79 SMN1; SMN2 (0.46) ALDH1A1SMN1; SMN2PPIDMAPTLMNA
SCHEMBL23771890 0.72 MAPT (0.46) ALDH1A1SMN1; SMN2MAPTLMNAGAA
SCHEMBL7538405 0.72 SMN1; SMN2 (0.66) ALDH1A1SMN1; SMN2MAPTLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3342771-B1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2020-11-25 EP disclosed
EP-3375780-B1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2020-06-03 EP disclosed
EP-3342771-A1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GlaxoSmithKline Intellectual Property Development Ltd (GB) 2018-07-04 EP disclosed
EP-2956452-B1 HETEROCYCLIC AMIDES AS KINASE INHIBITORS GLAXOSMITHKLINE IP DEV LTD (GB) 2018-03-21 EP disclosed